Response to dual HER2 blockade in a patient withHER3-mutant metastatic breast cancer

Targeting HER2 for the Treatment of Breast Cancer

(2015) Mothaffar F. Rimawi et al.   Annual Review of Medicine

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

(2014) C Daveau et al.   BRITISH JOURNAL OF CANCER

PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ--Implications for Progression to Invasive Breast Carcinoma

(2014) R. A. Sakr et al.   CLINICAL CANCER RESEARCH

Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast

(2014) Rachael Natrajan et al.   JOURNAL OF PATHOLOGY

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

(2014) François-Clément Bidard et al.   LANCET ONCOLOGY

Integrative genomic and transcriptomic characterization of papillary carcinomas of the breast

(2014) Salvatore Piscuoglio et al.   Molecular Oncology

Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands

(2014) Ilan Weinreb et al.   NATURE GENETICS

Oncogenic ERBB3 Mutations in Human Cancers

(2013) Bijay S. Jaiswal et al.   CANCER CELL

Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia

(2013) Dan A. Landau et al.   CELL

Relapsed Classic E-Cadherin (CDH1)-Mutated Invasive Lobular Breast Cancer Shows a High Frequency of HER2 (ERBB2) Gene Mutations

(2013) J. S. Ross et al.   CLINICAL CANCER RESEARCH

Liver metastases from breast cancer: Surgical resection or not? A case-matched control study in highly selected patients

(2013) P. Mariani et al.   EJSO

Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

(2013) J. Gao et al.   Science Signaling

Overall Survival Benefit With Lapatinib in Combination With Trastuzumab for Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Final Results From the EGF104900 Study

(2012) Kimberly L. Blackwell et al.   JOURNAL OF CLINICAL ONCOLOGY

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Absolute quantification of somatic DNA alterations in human cancer

(2012) Scott L Carter et al.   NATURE BIOTECHNOLOGY

Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer

(2012) Ron Bose et al.   Cancer Discovery

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

(2008) Edurne Arriola et al.   LABORATORY INVESTIGATION